Kotra Industries Bhd (XKLS:0002) ROCE %: 13.85% (As of Mar. 2026)


XKLS:0002 Kotra Industries Bhd XKLS:0002
84 GF Score
Price RM3.71
GF Value RM4.33
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Kotra Industries Bhd ROCE %?

Kotra Industries Bhd XKLS:0002 84 ROCE % is 13.85% as of Mar. 2026. GuruFocus rates XKLS:0002 with a GF Score™ of 84/100 and a GF Value™ of RM4.33 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kotra Industries Bhd's annualized ROCE % for the quarter that ended in Mar. 2026 was 13.85%.

Kotra Industries Bhd  (XKLS:0002) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Kotra Industries Bhd ROCE % Related Terms

Kotra Industries Bhd ROCE % Historical Data

* Premium members only.

The historical data trend for Kotra Industries Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kotra Industries Bhd ROCE % Chart

Kotra Industries Bhd Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.80 25.54 25.62 20.55 18.15

Kotra Industries Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.81 16.94 16.37 16.55 13.85
XKLS:0002
84GF Score
Kotra Industries Bhd XKLS:0002
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kotra Industries Bhd ROCE % Calculation

Kotra Industries Bhd's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=51.383/( ( (338.988 - 61.044) + (348.453 - 60.273) )/ 2 )
=51.383/( (277.944+288.18)/ 2 )
=51.383/283.062
=18.15 %

Kotra Industries Bhd's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=43.536/( ( (363.904 - 54.03) + (371.176 - 52.225) )/ 2 )
=43.536/( ( 309.874 + 318.951 )/ 2 )
=43.536/314.4125
=13.85 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 13.85% mean?
Kotra Industries Bhd (XKLS:0002) has a ROCE % of 13.85% as of Mar. 2026.
Is Kotra Industries Bhd's ROCE % too high?
Kotra Industries Bhd's current ROCE % is 13.85%. The Drug Manufacturers industry median ROCE % is 7.00. Kotra Industries Bhd's value of 13.85% is 98% above this industry median. Overall, Kotra Industries Bhd has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's ROCE % compare to ZTS and UTHR?
Kotra Industries Bhd's ROCE % of 13.85% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Kotra Industries Bhd's value of 13.85% is 98% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kotra Industries Bhd's current ROCE % of 13.85% is 98% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current ROCE % is 13.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.33, compared to a current price of RM3.71 — trading 14.3% below its estimated fair value. The current ROCE % is 13.85% and 98% above the Drug Manufacturers industry median of 7.00. Kotra Industries Bhd's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current ROCE % is 13.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?

Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued. The current stock price of RM3.71 is trading 14.3% below its estimated GF Value™ of RM4.33. GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0002:

  • ROCE %: 13.85%
  • GF Value™: RM4.33 vs. price of RM3.71 (14.3% below fair value)
  • GF Score™: 84/100 with 2 warning signs
  • Industry Position: 98% above the Drug Manufacturers median

No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kotra Industries Bhd Business Description

Address Jalan TTC 12, No. 1, 2 & 3, Cheng Industrial Estate, Melaka, MYS, 75250
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
84GF Score

Get the complete analysis for XKLS:0002

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.71
Price
RM4.33
GF Value